Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Litemuppon Dec 01, 2016 7:29pm

64 Views

Post# 25543709

RE:RE:I can sense the fear

Dear Mr Time frame, I have read every post of your hoping to find some level of intelligence or facts that may support fundamentals, but sadly there is nothing in your posts other than your love for busy and other garbage. Why do you conduct yourself in such a manner.

timeframe wrote: Van1 now you r stealing quotes from the EAT board Directly quoted this afternoon. At least try to be original. People move on as you can see in less than 2 weeks .36 to .13 Only the sheep the novice and the bozos did not sell.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!